Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00199_DB06237_nanopub.RANjTpV3aLBKxIJ1o6X-irrxa7PLpm1j1ZsmZY9AqUjg4#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00199_DB06237 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00199_DB06237 label "DDI between Erythromycin and Avanafil - Co-administration with the moderate CYP3A4 inhibitor erythromycin resulted in an approximate 3.6-fold increase in AUC0-inf and 2.0-fold increase in Cmax of avanafil. [drugbank_resource:DB00199_DB06237]" assertion.
- drugbank_resource:DB00199_DB06237 identifier "drugbank_resource:DB00199_DB06237" assertion.
- drugbank_resource:DB00199_DB06237 title "DDI between Erythromycin and Avanafil - Co-administration with the moderate CYP3A4 inhibitor erythromycin resulted in an approximate 3.6-fold increase in AUC0-inf and 2.0-fold increase in Cmax of avanafil." assertion.
- drugbank:DB00199 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00199_DB06237 assertion.
- drugbank:DB06237 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00199_DB06237 assertion.